Target intelligence / Profile preview

Chromodomain-helicase-DNA-binding protein 2 mRNA (CHD2 mRNA)

Target
CHD2 mRNA
Molecular classification
mRNA, Chromatin remodeler (encoded protein family)
01

Overview

Chromodomain-helicase-DNA-binding protein 2 (CHD2) mRNA is the transcript of the CHD2 gene, which encodes a member of the SNF2-like family of ATP-dependent chromatin remodeling proteins [1][2]. The CHD2 protein plays a critical role in regulating gene expression by modifying chromatin structure, a process essential for normal embryonic development and neuronal differentiation [1][3]. Mutations in the CHD2 gene, typically resulting in haploinsufficiency, are a primary cause of CHD2-related neurodevelopmental disorders, which are characterized by early-onset epilepsy, intellectual disability, and autism spectrum disorders [3]. Because these conditions arise from insufficient protein levels, the CHD2 mRNA has become a focal point for RNA-targeted therapeutic interventions [4]. Experimental strategies, such as the use of antisense oligonucleotides (ASOs), aim to modulate the splicing or stability of CHD2 mRNA to increase the production of functional CHD2 protein [4]. These approaches, including technologies like Targeted Augmentation of Nuclear Gene Output (TANGO), seek to restore normal chromatin remodeling activity and alleviate the severe neurological symptoms associated with CHD2 deficiency [4]. [1] UniProt Consortium. "CHD2 - Chromodomain-helicase-DNA-binding protein 2 - Homo sapiens (Human)." UniProtKB, O14647. [2] National Center for Biotechnology Information (NCBI). "CHD2 chromodomain helicase DNA binding protein 2 [Homo sapiens (human)]." Gene ID: 1106. [3] Suls, A., et al. (2013). "De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy." Nature Genetics, 45(5), 557-561. [4] Stoke Therapeutics. "Pipeline: CHD2-related neurodevelopmental disorders." stoketherapeutics.com.

Other names
CHD-2 mRNAChromodomain helicase DNA binding protein 2 transcriptEEOC mRNA
02

Mechanism of action

Upregulation of protein expression via antisense oligonucleotide-mediated modulation of pre-mRNA splicing to increase productive mRNA levels and restore functional protein concentrations.

03

Biological functions

Chromatin remodelingATP-dependent DNA helicase activityRegulation of gene expressionNeurodevelopmentNeuronal differentiation
04

Disease associations

EpilepsyLennox-Gastaut syndromeDravet-like syndromeIntellectual disabilityAutism spectrum disorderMyoclonic encephalopathy
05

Safety considerations

Potential for CHD2 protein overexpression leading to toxic gain-of-functionOff-target effects of antisense oligonucleotidesInnate immune response to synthetic RNA/oligonucleotidesDelivery challenges to the central nervous system
06

Interacting drugs

Antisense oligonucleotides (experimental)

1 more in the full profile.

07

Biomarkers

CHD2 protein levels in cerebrospinal fluid or tissuesSeizure frequencyElectroencephalogram (EEG) patternsDevelopmental milestones

Beyond the preview

Go deeper on Chromodomain-helicase-DNA-binding protein 2 mRNA (CHD2 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromodomain-helicase-DNA-binding protein 2 mRNA (CHD2 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call